This report analyzes the market for products used to reduce excessive hemorrhage during surgery. In a surgical procedure, these products are used as adhesion agents to seal wounds and to repair damaged or weakened tissue. This report does not consider the revenue associated with the main surgery cost; rather, it considers the revenue spent on stoppage/minimization of damage to the adjacent tissue to minimize intraoperative and postoperative complications.
Due to their ease of application, these products improve the work efficiency of surgeons. Biosurgery products can be used to disinfect wounds with the help of maggots, and are used particularly for chronic infected wounds, which do not get treated by antibiotics. This report covers all of the existing applications of biosurgery products.
The global biosurgery market is segmented primarily by product type, application, source, and region. Biosurgery products are segmented by type into anti-adhesive agents, hemostatic agents, surgical sealing agents, bone-graft substitutes, and soft-tissue management. The application segments include cardiothoracic surgery, neurosurgery and spine surgery, orthopedic surgery, and general surgery. Based on source, the biosurgery market is segmented into biological and synthetic products.
Scope of the Report:
An overview of the global market for biosurgery.
Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Segmentation of the market on the basis of product type, source, application, and region.
In depth coverage of the market dynamics, technology trends, drivers, constraints, and key strategies.
Discussion of government regulations, medical associations & international regulatory agencies.